GLOBALBIOENERGIESGLOBALBIOENERGIESGLOBALBIOENERGIES

GLOBALBIOENERGIES

No trades
See on Supercharts
Market capitalization
‪34.95 M‬EUR
−0.482EUR
‪−8.66 M‬EUR
‪3.25 M‬EUR
‪15.76 M‬
Beta (1Y)
0.41

About GLOBALBIOENERGIES

CEO
Marc Delcourt
Headquarters
Evry
Founded
2008
ISIN
FR0011052257
FIGI
BBG001QG0CY9
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company was founded by Marc Delcourt and Philippe Marlière on October 6, 2008 and is headquartered in Evry, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALGBE is 1.840 EUR — it has decreased by 4.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange GLOBALBIOENERGIES stocks are traded under the ticker ALGBE.
ALGBE stock is 8.18% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is GLOBALBIOENERGIES there?
One year price forecast for GLOBALBIOENERGIES has a max estimate of 2.800 EUR and a min estimate of 2.400 EUR.
Yes, you can track GLOBALBIOENERGIES financials in yearly and quarterly reports right on TradingView.
ALGBE stock has fallen by 10.24% compared to the previous week, the month change is a 0.55% rise, over the last year GLOBALBIOENERGIES has showed a 14.81% decrease.
ALGBE net income for the last quarter is ‪−4.57 M‬ EUR, while the quarter before that showed ‪−4.08 M‬ EUR of net income which accounts for −11.93% change. Track more GLOBALBIOENERGIES financial stats to get the full picture.
Today GLOBALBIOENERGIES has the market capitalization of ‪34.99 M‬, it has increased by 2.18% over the last week.
No, ALGBE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALGBE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLOBALBIOENERGIES stock right from TradingView charts — choose your broker and connect to your account.
ALGBE reached its all-time high on May 26, 2015 with the price of 58.914 EUR, and its all-time low was 1.702 EUR and was reached on Oct 26, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLOBALBIOENERGIES technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLOBALBIOENERGIES stock shows the sell signal. See more of GLOBALBIOENERGIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GLOBALBIOENERGIES future price: according to them, ALGBE price has a max estimate of 2.80 EUR and a min estimate of 2.40 EUR. Read a more detailed GLOBALBIOENERGIES forecast: see what analysts think of GLOBALBIOENERGIES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLOBALBIOENERGIES EBITDA is ‪−12.60 M‬ EUR, and current EBITDA margin is −377.13%. See more stats in GLOBALBIOENERGIES financial statements.